Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Weight loss, long considered an uphill battle for many, is finally becoming a more achievable goal for patients struggling to break free from the cycle of OSA and obesity. Not Without Risks While ...

These two conditions exacerbate each other, creating a vicious cycle that increases the risk of cardiovascular diseases.